HOME >> MEDICINE >> NEWS
Cure for hepatitis C announced by VCU researcher

RICHMOND, Va. (May 21, 2007) The use of peginterferon alone, or in combination with ribavirin, points to a cure for hepatitis C, the leading cause of cirrhosis, liver cancer and the need for liver transplant, a Virginia Commonwealth University researcher said today.

Mitchell Shiffman, M.D., professor in the VCU School of Medicine, and chief of hepatology and medical director of the Liver Transplant Program at the Virginia Commonwealth University Medical Center, is one of the lead investigators in the study, which was presented at the 38th annual Digestive Disease Week conference in Washington, D.C. VCU was among about 40 sites worldwide studying pegylated interferon alfa-2a, manufactured by Roche Inc.

Nearly all -- 99 percent of patients with hepatitis C who were treated successfully with peginterferon alone, or in combination with ribavirin, had no detectable virus up to seven years later. Researchers say this data validates the use of the word "cure" when describing hepatitis C treatment as successful treatment is defined as having undetectable hepatitis C virus in the blood six months following treatment.

"We at VCU are encouraged by this data because it is rare in the treatment of life-threatening viral diseases that we can tell patients they may be cured," Shiffman said. "In hepatitis C today, we are able to help some patients achieve an outcome that effectively enables them to put their disease behind them."

The results are based on a long-term follow-up study designed to determine if the virus re-emerges in patients who have achieved treatment success. The study reviewed 997 patients, either mono-infected with chronic HCV or co-infected HCV and HIV, who achieved a sustained viral response (SVR) following treatment with either Pegasys (peginterferon alfa-2a) monotherapy or combination therapy with Pegasys and ribavirin.

After successful treatment, researchers monitored serum levels of HCV once a year f
'"/>

Contact: Anne Buckley
albuckley@vcu.edu
804-828-6052
Virginia Commonwealth University
21-May-2007


Page: 1 2

Related medicine news :

1. UK and other European countries should introduce universal childhood hepatitis B vaccination
2. Liver cancer patients with high serum levels of hepatitis B virus face poorer outcomes
3. The hepatitis C link: Diagnose, treat, transplant
4. Could statins be a new option for hepatitis C patients?
5. Risk of lymphoma increases with hepatitis C virus infection
6. Outcomes for patients with hepatitis B who need liver transplants
7. Interferon-treated hepatitis C patients likely to experience retinopathy
8. Racial differences seen in steatosis in patients with hepatitis C
9. MGH study examines impact of infection with both HIV and hepatitis C virus
10. Making headway against hepatitis C: SLU study shows new drug combo effective in nonresponders
11. African Americans have lower response rate to standard therapy for hepatitis C

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/1/2020)... ... ... As fall and winter swiftly approach and many businesses cut costs to ... time to expand and grow into a full-fledged natural health clinic over the past ... relaunching its brand new website, expanding its services menu and has recruited top-tier healthcare ...
(Date:8/31/2020)... , ... August 31, 2020 , ... Just found out your dear friend has cancer? ... when your friend or family member shares their diagnosis. Once the shock wears off, the ... the wrong thing? What are the best ways to help? Words are failing me. I’m ...
(Date:8/31/2020)... ... August 31, 2020 , ... Colorado State University ... career-relevant, and affordable online education – is proud to announce its new master’s ... first of its kind in the nation, the 60-credit hour program is designed ...
(Date:8/31/2020)... ... 2020 , ... In an effort to give back to the community in ... each hotel room booked with a special new rate code to benefit children and ... effective immediately. Donations will be applied to any room type, any time, now ...
(Date:8/28/2020)... JACKSONVILLE, Fla. (PRWEB) , ... August 28, 2020 ... ... that Forcura’s Founder & CEO Craig Mandeville was named an Entrepreneur Of The ... The Year program honors entrepreneurial business leaders whose ambitions deliver innovation, growth and ...
Breaking Medicine News(10 mins):
(Date:8/27/2020)... ... August 27, 2020 , ... ... announced the successful completion of their 2020 System and Organizational Controls (SOC) 1® ... interim assessment and MARS-E compliance assessment. These achievements reflect their long-standing commitment to ...
(Date:8/27/2020)... ... ... flu season is right round the corner and the risk of getting caught by influenza ... it begins to harbor its effects on us. Already with the sudden outbreak of COVID ... our lives. Hence it has become even more relevant to keep oneself immune from any ...
(Date:8/27/2020)... ... August 27, 2020 , ... Trella Health, ... a leading provider of cloud CRM, marketing automation, and contact center solutions for ... involve the integration of Trella’s performance intelligence data and insights into Enquire’s CRM ...
Breaking Medicine Technology:
Cached News: